BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 90 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $676,000 | -14.3% | 13,650 | -5.2% | 0.01% | -14.3% |
| Q1 2017 | $789,000 | +0.4% | 14,406 | +2.1% | 0.01% | -6.7% |
| Q4 2016 | $786,000 | +22.4% | 14,113 | +0.4% | 0.02% | +25.0% |
| Q3 2016 | $642,000 | +14.2% | 14,057 | -0.1% | 0.01% | +9.1% |
| Q2 2016 | $562,000 | +21.1% | 14,072 | +5.7% | 0.01% | +22.2% |
| Q1 2016 | $464,000 | -37.2% | 13,317 | -22.6% | 0.01% | -35.7% |
| Q4 2015 | $739,000 | -14.7% | 17,209 | -13.4% | 0.01% | -17.6% |
| Q3 2015 | $866,000 | -40.2% | 19,880 | -29.1% | 0.02% | -34.6% |
| Q2 2015 | $1,447,000 | +76.0% | 28,035 | +33.6% | 0.03% | +73.3% |
| Q1 2015 | $822,000 | +18.8% | 20,987 | +17.1% | 0.02% | +15.4% |
| Q4 2014 | $692,000 | +16.3% | 17,916 | +6.2% | 0.01% | +18.2% |
| Q3 2014 | $595,000 | +58.2% | 16,869 | +21.0% | 0.01% | +57.1% |
| Q2 2014 | $376,000 | -30.6% | 13,936 | -33.3% | 0.01% | -30.0% |
| Q1 2014 | $542,000 | – | 20,893 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |